This site is intended for healthcare professionals

Go to /pro/cpd-dashboard page

This video is worth 0.05 CPD credits. CPD Dashboard

Go to /account/subscription-details page

This video is worth 0.05 CPD credits. Upgrade to Pro

Esmya (ulipristal acetate): suspension of the licence

Posted 3 Apr 2020

Dr Julie Oliver

Julie Oliver summarises information from the MHRA regarding the suspension of the licence for Esmya (ulipristal acetate) while a safety review is conducted.

Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.